Search filters

List of works by Noriyoshi Iriyama

A novel fusion gene involving PDGFRB and GCC2 in a chronic eosinophilic leukemia patient harboring t(2;5)(q37;q31)

article

Clinical effect of immunophenotyping on the prognosis of multiple myeloma patients treated with bortezomib

scientific article

Comparison of the clinical outcomes of nilotinib and dasatinib therapies in newly diagnosed patients in the chronic phase of chronic myeloid leukemia: a retrospective analysis

scientific article published on 07 September 2018

Direct effect of dasatinib on signal transduction pathways associated with a rapid mobilization of cytotoxic lymphocytes.

scientific article published on 10 October 2016

Enhanced perforin expression associated with dasatinib therapy in natural killer cells

scientific article published on 24 February 2018

Incidences and outcomes of therapy-related chronic myeloid leukemia in the era of tyrosine kinase inhibitors: Surveillance of the CML Cooperative Study Group

scientific article published on 5 January 2017

Lyn, a tyrosine kinase closely linked to the differentiation status of primary acute myeloid leukemia blasts, associates with negative regulation of all-trans retinoic acid (ATRA) and dihydroxyvitamin D3 (VD3)-induced HL-60 cells differentiation.

scientific article published on 13 May 2016

MPC-1 expression in myeloma cells is associated with the efficacy of bortezomib therapy

scientific article published on 24 July 2019

Plasma cell maturity as a predictor of prognosis in multiple myeloma

scientific article published on 6 July 2016

Smoking influences the outcomes of patients receiving tyrosine kinase inhibitors for chronic myeloid leukemia in the chronic phase: A retrospective analysis

scientific article published on 26 April 2019

The EUTOS long-term survival score predicts disease-specific mortality and molecular responses among patients with chronic myeloid leukemia in a practice-based cohort

scientific article published on 10 October 2020

The Efficacy of Reduced-dose Dasatinib as a Subsequent Therapy in Patients with Chronic Myeloid Leukemia in the Chronic Phase: The LD-CML Study of the Kanto CML Study Group.

scientific article

The cyclin-dependent kinase 4/6 inhibitor, abemaciclib, exerts dose-dependent cytostatic and cytocidal effects and induces autophagy in multiple myeloma cells.

scientific article published on 18 September 2017

Paulina is supported by:

About Paulina

Help